Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 27 of 1,261
  1. US 12365711

    TGFβ signal convertor

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  2. US 12364745

    Immunogenicity of a CpG-adjuvanted recombinant plague vaccine

    The Government of the United States, as represented by the Secretary of the Army · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  3. US 12364609

    Biomimetic implants

    The Regents of the University of California · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  4. US 12365719

    CD80 extracellular domain polypeptides and their use in cancer treatment

    Five Prime Therapeutics, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  5. US 12365653

    Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  6. US 12365761

    Biodegradable ultra-pH sensitive polymers

    The Board of Regents of the University of Texas System · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  7. US 12365889

    Tunable nanoscale cages from self-assembling DNA and protein building blocks

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  8. US 12364753

    CD8 binding agents

    Orionis Biosciences, Inc · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  9. US 12364693

    Methods of treating metabolic diseases with fused bicyclic pyrazoles

    Belite Bio, Inc · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  10. US 12364668

    Treatment of opioid use disorder, opioid withdrawal symptoms, and chronic pain

    The Regents of the University of California · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  11. US 12364671

    Methods of administering vitamin A and lactic acid to gilts

    China Agricultural University · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  12. US 12364680

    Compounds for treating ophthalmic diseases and disorders

    KIORA PHARMACEUTICALS GmbH · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  13. US 12364670

    Cannabidiol-type cannabinoid compound

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  14. US 12364774

    Nucleic acid molecules and uses thereof for non-viral gene therapy

    BIOVERATIV THERAPEUTICS INC. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  15. US 12364775

    Viral vectors for cancer therapy

    Krystal Biotech, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  16. US 12364762

    Biodegradable lipids for the delivery of active agents

    Alnylam Pharmaceuticals, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  17. US 12365664

    Small molecule inhibitors of SRC tyrosine kinase

    The Board of Regents of the University of Texas System · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  18. US 12364764

    Sustained release thermosetting gels comprising sodium channel blockers and the methods of making same

    Pacira Therapeutics, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  19. US 12364736

    Methods for treating heterotopic ossification

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  20. US 12365728

    DLL3 single domain antibodies and therapeutic compositions thereof

    Inhibrx Biosciences, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  21. US 12365688

    Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors

    Revolution Medicines, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  22. US 12364683

    Non-sedating dexmedetomidine treatment regimens

    BioXcel Therapeutics, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  23. US 12364708

    Injectable scaffold for treatment of intracranial aneurysms and related technology

    Covidien LP · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  24. US 12365693

    Compositions and methods for treating cancer

    The Regents of the University of California · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.